The effectiveness of chemical restraint in managing acute agitation and aggression: A systematic review of randomized controlled trials.
International Journal of Mental Health Nursing · 2019-09-09 · Systematic review
Abstract
One approach to manage people with behaviours of concern including agitated or aggressive behaviours in health care settings is through the use of fast-acting medication, called chemical restraint. Such management often needs to be delivered in crisis situations to patients who are at risk of harm to themselves or others. This paper summarizes the available evidence on the effectiveness and safety of chemical restraint from 21 randomized controlled trials (RCTs) involving 3788 patients. The RCTs were of moderate to high quality and were conducted in pre-hospital, hospital emergency department, or ward settings. Drugs used in chemical restraint included olanzapine, haloperidol, droperidol, risperidol, flunitrazepam, midazolam, promethazine, ziprasidone, sodium valproate, or lorazepam. There was limited comparability between studies in drug choice, combination, dose, method of administration (oral, intramuscular, or intravenous drip), or timing of repeat administrations. There were 31 outcome measures, which were inconsistently reported. They included subjective measures of behaviours, direct measures of treatment effect (time to calm; time to sleep), indirect measures of agitation (staff or patient injuries, duration of agitative or aggressive episodes, subsequent violent episodes), and adverse events. The most common were time to calm and adverse events. There was little clarity about the superiority of any chemical method of managing behaviours of concern exhibited by patients in Emergency Departments or acute mental health settings. Not only is more targeted research essential, but best practice recommendations for such situations requires integrating expert input into the current evidence base.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Sedatives & anxiolytics · Midazolam · Other drugs · Antihistamines · Antipsychotics
Related articles
- [Haloperidol plus promethazine for agitated patients--a systematic review]. (Braz J Psychiatry, 2009)
- Rapid tranquillisation in a psychiatric emergency hospital in Lebanon: TREC-Lebanon - a pragmatic randomised controlled trial of intramuscular haloperidol and promethazine v. intramuscular haloperidol, promethazine and chlorpromazine. (Psychol Med, 2022)
- Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine. (Br J Psychiatry, 2004)
- Exploring Current Emergency Medical Services Approaches to Manage Agitated Older Adult Patients: An Analysis of Statewide Protocols. (J Am Geriatr Soc, 2026)
- Review, clinical update, and practice guidelines for excited delirium syndrome. (J Spec Oper Med, 2015)
- Efficacy and safety of intramuscular and intravenous midazolam for acute agitation in emergency settings: a systematic review. (Int Clin Psychopharmacol, 2026)